Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 2/20 | 0.50 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | EPAS1 | Q99814 | 7/20 | 0.45 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.44 |
| ▸ | FNTA | P49354 | 1/20 | 0.44 |
| ▸ | FNTB | P49356 | 1/20 | 0.44 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.44 |
| ▸ | VEGFA | P15692 | 2/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7069917 | 0.85 | CYP19A1 (0.58) | ARALDH1A1SMN1; SMN2EPAS1CYP19A1 | |
| SCHEMBL7069974 | 0.83 | PDE4A (0.50) | ARALDH1A1SMN1; SMN2EPAS1CYP19A1 | |
| SCHEMBL7072557 | 0.83 | PDE4A (0.50) | ARALDH1A1SMN1; SMN2EPAS1CYP19A1 | |
| SCHEMBL7070749 | 0.83 | SMN1; SMN2 (0.50) | ARALDH1A1SMN1; SMN2EPAS1CYP19A1 | |
| SCHEMBL7075721 | 0.81 | AR (0.49) | ARALDH1A1SMN1; SMN2EPAS1CYP19A1 | |
| SCHEMBL7074501 | 0.81 | CYP19A1 (0.48) | ARALDH1A1SMN1; SMN2EPAS1CYP19A1 | |
| SCHEMBL23795068 | 0.80 | CYP19A1 (0.59) | ARALDH1A1SMN1; SMN2EPAS1SLC22A12 | |
| SCHEMBL7073983 | 0.80 | CYP19A1 (0.54) | ARALDH1A1SMN1; SMN2CYP19A1FFAR1 | |
| SCHEMBL27839327 | 0.79 | PDE4A (0.53) | ARALDH1A1SMN1; SMN2EPAS1CYP19A1 | |
| SCHEMBL7073821 | 0.78 | AR (0.55) | ARALDH1A1SMN1; SMN2SLC22A12CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030181334-A1 | Herbicidal method | BAYER CROPSCIENCE LIMITED (GB) | 2003-09-25 | — | — | US | disclosed |
| WO-2003051119-A1 | NEW HERBICIDAL COMPOUNDS AND METHOD | BAYER CROPSCIENCE LIMITED (GB) | 2003-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030181334-A1 | Herbicidal method | DDT, HAAO, CYP4X1 | AR 4356/4885LRRK2 3905/4885ALDH1A1 184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.